| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5686558 | The Journal of Urology | 2017 | 30 Pages |
Abstract
Our data demonstrate that patient responses to high dose interleukin-2 and to targeted agents before and after receiving high dose interleukin-2 are independent. As such, carefully selected patients should be offered high dose interleukin-2 for the possibility of a complete and durable response without the fear of limiting the treatment benefit of targeted agents.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jessie Gills, William P. Parker, Scott Pate, Sida Niu, Peter Van Veldhuizen, Moben Mirza, Jeffery M. Holzbeierlein, Eugene K. Lee,